CONGRESS GUIDE

ERS International Congress 2016
DETAILED PROGRAMME
SUNDAY 04 SEPTEMBER, 2016
OA262
OA263
Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension
Carole Phan (Le Plessis-Robinson, France), Carole Phan, Andrei Seferian, Alice Huertas, Ly Tu, Raphael Thuillet, Caroline
Sattler, Morane Le Hiress, Yuichi Tamura, Etienne-Marie Jutant, Marie-Camille Chaumais, Stéphane Bouchet, Benjamin
Manéglier, Mathieu Molimard, Philippe Rousselot, Olivier Sitbon, Gérald Simonneau, David Montani, Marc Humbert,
Christophe Guignabert
RESPITE: Riociguat in pulmonary arterial hypertension patients with an inadequate response to phosphodiesterase
type 5 inhibitors
Marius M. Hoeper (Hannover, Germany), Marius M. Hoeper, Paul A. Corris, James R. Klinger, David Langleben, Robert
Naeije, Gérald Simonneau, Raymond L. Benza
OA264
Hyperoxia enhances exercise performance in PAH and CTEPH: Randomized trial
Silvia Ulrich (Zürich, Switzerland), Silvia Ulrich, Elisabeth Hasler, Stéphanie Saxer, Michael Furian, Séverine Müller-
Mottet, Stephan Keusch, Konrad Bloch
Room D Session 119 08:30 - 10:30
Oral Presentation: Best abstracts in pulmonary rehabilitation and chronic care
Aims : Five selected abstracts are in competition and will be presented first. The outcome results will be presented at the end of the
session. The prizes are financially supported by Invacare.
Chairs : Ioannis Vogiatzis (Athens, Greece), Frits M.E. Franssen (Horn, Netherlands)
OA265
OA266
OA267
OA268
OA269
OA270
OA271
Skeletal muscle function and structure in patients with non-cystic fibrosis bronchiectasis
Diego Augustin Rodriguez (Barcelona, Spain), Ana Balañá, Juana Martínez-Llorens, Diego Agustin Rodríguez, Mireia
Admetlló, Anna Salazar, Pilar Ausin, Esther Barreiro, Joaquin Gea
Physiological effects of nutritional supplementation as adjunct to exercise training in COPD patients with low muscle
mass. The double blind, placebo controlled multi-centre NUTRAIN-trial
Coby van de Bool (Neer, Netherlands), Coby Van de Bool, Erica Ruten, Ardy van Helvoort, Frits Franssen, Emiel Wouters,
Annemie Schols
Exercise training improves peak oxygen consumption and hemodynamics in patients with pulmonary hypertension –
A prospective, randomized, controlled trial
Nicola Benjamin (Heidelberg, Germany), Nicola Benjamin, Hans Klose, Mona Lichtblauf, Johannes Weidenhammer,
Christine Fischer, Robert Nechwatal, Sören Uiker, Michael Halank, Karen Olsson, Werner Seeger, Henning Gall, Stephan
Rosenkranz, Heinrike Wilkens, Dirk Mertens, Hans-Jürgen Seyfarth, Christian Opitz, Silvia Ulrich, Benjamin Egenlauf,
Ekkehard Grünig
Home telerehabilitation maintenance program for patients affected by COPD and CHF
Mara Paneroni (Mazzano, Italy), Mara Paneroni, Simonetta Scalvini, Palmira Bernocchi, Tiziana Galli, Doriana Baratti,
Maria Teresa La Rovere, Maurizio Volterrani, Michele Vitacca
Minimal versus specialist equipment for the delivery of pulmonary rehabilitation in COPD
Melanie Palmer (Uxbridge, United Kingdom), Melanie Palmer, Sarah Jones, Claire Nolan, Jane Canavan, Alex Labey,
Matthew Maddocks, Samantha Kon, William Man
Early diaphragm pacing to delay non-invasive ventilation in patients with amyotrophic lateral sclerosis
(RespiStimALS): A multicenter, triple-blind, randomized controlled trial
Jesus Gonzalez Bermejo (Montlignon, France), Jesus Gonzalez Bermejo, Capucine Morelot-Panzini, Tanguy Marie Laure,
Vincent Meininger, Philippe Couratier, Nathalie Guy, Claude Desnuelle, Hélène Prigent, Christophe Perrin, Valérie Attali,
Nierat Marie-Cecile, Francois Salachas, Thomas Similowski
Sarcopenia and associated factors in older adults with COPD: Results from the SABE-Bogota cohort study
Carlos Andrès Celis Preciado (Bogota, Cundinamarca, Colombia), Carlos Andrés Celis Preciado, Miguel Borda, Mario
Pérez-Cepeda, Carlos Cano
OA6011
Ceremony: announcement of the ranking for the 5 Best abstracts in pulmonary rehabilitation and chronic care
Richard Casaburi (Rancho Palos Verdes, United States of America), Nicolino Ambrosino (Volterra, Italy)
Room M Session 120 08:30 - 10:30
Oral Presentation: Clinical update on bronchiectasis
Chairs : Charles Haworth (Cambridge, United Kingdom), Menno M. van der Eerden (Rotterdam, Netherlands)
OA272
LATE-BREAKING ABSTRACT: RESPIRE 1: Ciprofloxacin DPI 32.5mg b.d. administered 14 day on/off or 28 day
on/off vs placebo for 48 weeks in subjects with non-cystic fibrosis bronchiectasis (NCFB)
Anthony De Soyza (Newcastle-upon-Tyne, United Kingdom), Anthony De Soyza, Timothy Aksamit, Tiemo-Joerg Bandel,
Margarita Criollo, J. Stuart Elborn, Ulrike Krahn, Elisabeth Operschall, Eva Polverino, Kevin Winthrop, Robert Wilson
27 26.08.2016